-+ 0.00%
-+ 0.00%
-+ 0.00%

CONDUIT PHARMACEUTICALS RECEIVES FURTHER PATENT APPROVAL FOR ITS LEAD ASSET TARGETING AUTOIMMUNE DISEASES

Reuters·05/09/2025 12:30:46

Please log in to view news